Given CNPY2’s role in regulating ER stress and hypoxia responses, one can hypothesize that its expression in CAFs—if elevated—could reshape the stromal “niche”, fostering further tumor invasiveness and immune suppression. This evidence concerns the gene CNPY2 and neoplasm.